New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

34

Byondis’ ADC Candidate Shows Prolonged PFS in HER-2+ Advanced Breast Cancer

Topline results from the Phase III TULIP study show an antibody-drug conjugate (ADC) from the Netherlands-based Byondis B.V. significantly prolonged progression-free survival (PFS) in patients with pretreated HER2-positive unresectable locally advanced or metastatic breast cancer (MBC).

36

Adhera, Bayer Subsidiaries Targeting Parkinson’s with Novel Approaches

Working through two subsidiaries, life sciences giant Bayer is taking multiple shots at Parkinson’s disease. In addition to Bayer’s efforts to tackle Parkinson’s, Adhera Therapeutics announced that the company will acquire a new class of drug aimed at the disease.

39

Fishawack Health Acquires Analytics-Driven Digital Marketing Agency, closerlook

Fishawack Health, a leading global commercialization partner for the life sciences industry, announced the acquisition of Chicago-based closerlook LLC. closerlook is a digital-native healthcare agency that leverages artificial intelligence (AI) and data analytics to develop omnichannel strategies, creative and digital media solutions for life science brands across the entire pre-commercial and commercial lifecycle of a drug.

40

U.S. report concluded Covid-19 may have leaked from Wuhan lab – WSJ

A report on the origins of Covid-19 by a U.S. government national laboratory concluded that the hypothesis of a virus leak from a Chinese lab in Wuhan is plausible and deserves further investigation, the Wall Street Journal said on June 7, citing people familiar with the classified document.